Institutional Ownership Tango Therapeutics, Inc. (TNGX)
This table provides information about the institutional ownership of Tango Therapeutics, Inc. (TNGX). We have compiled data on the 120 institutions that hold shares in the stock, with a total of 97.9 Million shares, which have been reported (via 13F filing form) to have a value of $672 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Trv Gp Iv, LLC
Boston, MA |
May 09, 2025 Q1 2025 |
16,859,075
shares
|
$116 Million
88.92% of portfolio
|
Q3 2024
Reduced 12.2%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
May 14, 2025 Q1 2025 |
10,736,000
shares
|
$73.6 Million
3.54% of portfolio
|
Q4 2024
New holding
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
10,630,736
shares
|
$72.9 Million
1.14% of portfolio
|
Q4 2024
Reduced 20.25%
|
|
|
Nextech Invest, Ltd.
Zurich, V8 |
May 15, 2025 Q1 2025 |
5,533,980
shares
|
$38 Million
1.76% of portfolio
|
Q1 2025
New holding
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
5,533,980
shares
|
$38 Million
3.19% of portfolio
|
Q3 2023
New holding
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
4,610,930
shares
|
$31.6 Million
0.04% of portfolio
|
Q1 2025
Added 15.27%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,987,852
shares
|
$27.4 Million
0.0% of portfolio
|
Q2 2024
Added 3.28%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
3,875,545
shares
|
$26.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.75%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 14, 2025 Q1 2025 |
3,312,449
shares
|
$22.7 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.99%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
3,219,571
shares
|
$22.1 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.82%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
May 15, 2025 Q1 2025 |
2,987,983
shares
|
$20.5 Million
0.18% of portfolio
|
Q1 2025
Added 6.55%
|
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
2,712,008
shares
|
$18.6 Million
1.25% of portfolio
|
Q3 2024
Reduced 6.25%
|
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
2,565,342
shares
|
$17.6 Million
0.2% of portfolio
|
Q1 2025
Reduced 1.48%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
May 15, 2025 Q1 2025 |
2,121,652
shares
|
$14.6 Million
1.5% of portfolio
|
Q1 2025
Added 22.49%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
1,842,163
shares
|
$12.6 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
1,470,932
shares
|
$10.1 Million
0.0% of portfolio
|
Q1 2025
Added 489.21%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,383,437
shares
|
$9.49 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.22%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
1,144,443
shares
|
$7.85 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.05%
|
|
|
Acadian Asset Management LLC
Boston, MA |
May 21, 2025 Q1 2025 |
973,309
shares
|
$6.68 Million
0.0% of portfolio
|
Q1 2025
Added 96.59%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
737,955
shares
|
$5.06 Million
0.0% of portfolio
|
Q1 2025
Added 42.62%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
May 15, 2025 Q1 2025 |
708,385
shares
|
$4.86 Million
0.02% of portfolio
|
Q4 2023
New holding
|
|
|
Bessemer Group Inc
Woodbridge, NJ |
Apr 23, 2025 Q1 2025 |
708,384
shares
|
$4.86 Million
0.0% of portfolio
|
Q2 2022
New holding
|
|
|
Schroder Investment Management Group
London, X0 |
May 13, 2025 Q1 2025 |
655,158
shares
|
$4.49 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
May 15, 2025 Q1 2025 |
630,000
shares
|
$4.32 Million
0.4% of portfolio
|
Q1 2023
New holding
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
605,290
shares
|
$4.15 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.67%
|